119-HR-7094 Journalist Public Summary

Headline Summary

A bipartisan proposal would bar U.S. companies and individuals—and their overseas subsidiaries—from supplying petroleum equipment, software, or services to Russia’s energy sector, carving out limited medical-isotope uses and adding penalties for violators. (doggett.house.gov)

What It Does

In plain terms, the bill tells the President to stop U.S. persons (wherever they are) from exporting or providing petroleum equipment and services to Russia. It also makes U.S.-owned or -controlled foreign subsidiaries subject to the same ban, allows a narrow exception for certain isotopes used in medicine, agriculture, or environmental work, and calls for penalties on foreign violators (like asset freezes and visa bans). The administration would implement and enforce the rules, with time-limited national‑security waivers possible. (doggett.house.gov)

Who’s For It

• Sponsors and early backers: Rep. Lloyd Doggett (D‑TX) and a bipartisan group including Reps. Don Bacon (R‑NE), Gus Bilirakis (R‑FL), Steve Cohen (D‑TN), Brian Fitzpatrick (R‑PA), Dan Goldman (D‑NY), Tom Kean Jr. (R‑NJ), Eleanor Holmes Norton (D‑DC), and Mike Quigley (D‑IL). (doggett.house.gov)
• Endorsing organizations cited by the sponsor include Razom for Ukraine, the Ukrainian Congress Committee of America (UCCA), B4Ukraine, and FDD Action. (doggett.house.gov)
• Supporters say cutting off U.S. equipment, software, and expertise helps reduce Russia’s energy revenues that fund its war against Ukraine. (doggett.house.gov)

Who’s Against It

• As of January 16, 2026, no formal opposition has been publicly noted.
• Possible concerns some may raise: added compliance burdens for U.S. firms (especially those with foreign subsidiaries), potential business impacts on oilfield services companies, and the need to ensure humanitarian and medical exceptions are clear and workable.

What’s Next

The bill was introduced on January 15, 2026, and sent to the House Foreign Affairs Committee and, additionally, the Judiciary Committee. That means it’s at the committee stage; next steps could include hearings, amendments, and a committee vote before any full House consideration. (quiverquant.com)